Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (241-250 of 509) with videos related to

Pageof 51
Sort By:
AIDS (London, England)|May 12, 2017
Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individualsLene Ryom, Amanda Mocroft, Ole Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2019
Neurocognitive Development in Perinatally Human Immunodeficiency Virus-infected Adolescents on Long-term Treatment, Compared to Healthy Matched Controls: A Longitudinal StudyMalon Van den Hof, Anne Marleen Ter Haar, Henriette J Scherpbier, et al.
AIDS (London, England)|December 22, 2007
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyRegje Me Blümer, Marit Ga van Vonderen, Jussi Sutinen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2008
Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort studyFerdinand W N M Wit, Anouk M Kesselring, Luuk Gras, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
AIDS (London, England)|October 3, 2003
Mortality and progression to AIDS after starting highly active antiretroviral therapyArd I van Sighem, Mark A van de Wiel, Azra C Ghani, et al.
Plos Computational Biology|April 27, 2026
Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approachRachel Mac Cann, Dana Alalwan, Gurvin Saini, et al.
Open Forum Infectious Diseases|July 3, 2019
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive ImpairmentJonathan Underwood, Davide De Francesco, James H Cole, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2013
Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE studyAoife G Cotter, Saskia M E Vrouenraets, Jennifer J Brady, et al.
Journal of Virus Eradication|June 30, 2022
Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infectionPien van Paassen, Maartje Dijkstra, Holly L Peay, et al.
Pageof 51

Showing results (241-250 of 509) with videos related to

Sort By:
Pageof 51
AIDS (London, England)|May 12, 2017
Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individualsLene Ryom, Amanda Mocroft, Ole Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2019
Neurocognitive Development in Perinatally Human Immunodeficiency Virus-infected Adolescents on Long-term Treatment, Compared to Healthy Matched Controls: A Longitudinal StudyMalon Van den Hof, Anne Marleen Ter Haar, Henriette J Scherpbier, et al.
AIDS (London, England)|December 22, 2007
Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapyRegje Me Blümer, Marit Ga van Vonderen, Jussi Sutinen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2008
Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort studyFerdinand W N M Wit, Anouk M Kesselring, Luuk Gras, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
AIDS (London, England)|October 3, 2003
Mortality and progression to AIDS after starting highly active antiretroviral therapyArd I van Sighem, Mark A van de Wiel, Azra C Ghani, et al.
Plos Computational Biology|April 27, 2026
Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approachRachel Mac Cann, Dana Alalwan, Gurvin Saini, et al.
Open Forum Infectious Diseases|July 3, 2019
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive ImpairmentJonathan Underwood, Davide De Francesco, James H Cole, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2013
Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE studyAoife G Cotter, Saskia M E Vrouenraets, Jennifer J Brady, et al.
Journal of Virus Eradication|June 30, 2022
Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infectionPien van Paassen, Maartje Dijkstra, Holly L Peay, et al.
Pageof 51